SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 142.14 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 591.48 |
| Book Value / Share | 3.79 |
| Price / Book | n/a |
| NCAV ($M) | -231.66 |
| NCAV / Share | -1.46 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.43 |
| Return on Assets (ROA) | -0.36 |
| Return on Equity (ROE) | -0.94 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.58 |
| Current Ratio | 3.52 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 341.08 |
| Assets | 1,164.22 |
| Liabilities | 572.74 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 3,286,070 | 6,872,878 | 47.81 | |
| 2,792,464 | 7,799,724 | 35.80 | |
| 2,700,894 | 7,019,831 | 38.48 | |
| 3,790,230 | 10,963,112 | 34.57 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BPMC – Blueprint Medicines Corporation | CABA – Cabaletta Bio, Inc. |
| CCCC – C4 Therapeutics, Inc. | CGEM – Cullinan Therapeutics, Inc. |
| CGON – CG Oncology, Inc. |